Abbott (ABT) reportedly seeks USD 20bln in US bond sales for Exact Science (EXAS) deal, Bloomberg News

Abbott's reported plan to raise USD 20 billion through bond sales for its acquisition of Exact Sciences signals a significant strategic move in the healthcare sector.

Newsquawk StaffPublished On the live feed at 10 more headlines followed before this page went public
Newsquawk headlinesUTC

Microsoft (MSFT) announces that it's investigating a US user issues with 504 gateway timeout errors

Freeport-McMoRan (FCX) CEO states that new tariffs does not change the company's business

Abbott (ABT) reportedly seeks USD 20bln in US bond sales for Exact Science (EXAS) deal, Bloomberg News

[WATCH LIVE] President Trump Participates in Angel Families Remembrance Ceremony

EU's Kallas said EU did not reach an agreement on Russian sanctions package

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The large financing indicates a robust commitment to growth through M&A, which could impact market sentiment toward both Abbott and its peers, particularly in the healthcare equipment space. Investors will be keen to assess the structure of the deal and how it might affect Abbott's balance sheet and stock performance moving forward.

Related headlines

The whole workspace, free to try.

Try it free